Could a diabetes drug shield psoriatic arthritis patients from heart disease?
NCT ID NCT07251556
First seen Dec 10, 2025 · Last updated May 14, 2026 · Updated 21 times
Summary
This study looks at whether semaglutide, a drug used for diabetes, can slow down artery hardening in people with psoriatic arthritis who do not have diabetes. Psoriatic arthritis raises the risk of heart problems, and this drug may help by reducing inflammation and improving metabolism. About 40 participants will be randomly assigned to receive semaglutide or standard care, and their artery health will be checked with ultrasound over 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.